Skip to main content
Top
Published in: Translational Behavioral Medicine 1/2017

01-03-2017 | Practice and Public Health Policies

Leveraging corporate social responsibility to improve consumer safety of dietary supplements sold for weight loss and muscle building

Authors: Anvita Kulkarni, BA, Ryan Huerto, MD, MPH, Christina A. Roberto, PhD, S. Bryn Austin, ScD

Published in: Translational Behavioral Medicine | Issue 1/2017

Login to get access

Abstract

The potential dangers associated with dietary supplements sold for weight loss and muscle building are well documented and increasingly garnering the attention of the media, public, and government leaders. Public health professionals have an opportunity to improve population health in the context of dietary supplement use by translating scientific evidence into action. In this commentary, we discuss the potential to motivate corporate social responsibility (CSR) among manufacturers and retailers of dietary supplements sold for weight loss and muscle building. We examine levers available to public health professionals for generating voluntary corporate self-regulation by reviewing examples from successful CSR initiatives in other domains of public health and offering recommendations highlighting effective advocacy strategies. We encourage public health professionals to use one or multiple advocacy strategies to improve consumer protections for dietary supplements sold for weight loss and muscle building.
Literature
4.
go back to reference Neville A. IBIS World Industry Report: Online vitamin and supplement sales in the U.S.; 2015. Neville A. IBIS World Industry Report: Online vitamin and supplement sales in the U.S.; 2015.
5.
go back to reference Onakpoya, I. J., Wider, B., Pittler, M. H., & Ernst, E. (2011). Food supplements for body weight reduction: a systematic review of systematic reviews. Obesity, 19(2), 239–244.CrossRefPubMed Onakpoya, I. J., Wider, B., Pittler, M. H., & Ernst, E. (2011). Food supplements for body weight reduction: a systematic review of systematic reviews. Obesity, 19(2), 239–244.CrossRefPubMed
6.
go back to reference Cohen, P. A. (2014). Hazards of hindsight—monitoring the safety of nutritional supplements. N Engl J Med, 370(14), 1277–1280.CrossRefPubMed Cohen, P. A. (2014). Hazards of hindsight—monitoring the safety of nutritional supplements. N Engl J Med, 370(14), 1277–1280.CrossRefPubMed
7.
go back to reference Pomeranz, J. L., Barbosa, G., Killian, C., & Austin, S. B. (2015). The dangerous mix of adolescents and dietary supplements for weight loss and muscle building: legal strategies for state action. Journal of Public Health Management and Practice, 21(5), 496–503.CrossRefPubMed Pomeranz, J. L., Barbosa, G., Killian, C., & Austin, S. B. (2015). The dangerous mix of adolescents and dietary supplements for weight loss and muscle building: legal strategies for state action. Journal of Public Health Management and Practice, 21(5), 496–503.CrossRefPubMed
8.
go back to reference Li, N., Hauser, R., Holford, T., Zhu, Y., Zhang, Y., Bassig, B. A., et al. (2015). Muscle-building supplement use and increased risk of testicular germ cell cancer in men from Connecticut and Massachusetts. Br J Cancer, 112(7), 1247–1250.CrossRefPubMedPubMedCentral Li, N., Hauser, R., Holford, T., Zhu, Y., Zhang, Y., Bassig, B. A., et al. (2015). Muscle-building supplement use and increased risk of testicular germ cell cancer in men from Connecticut and Massachusetts. Br J Cancer, 112(7), 1247–1250.CrossRefPubMedPubMedCentral
9.
go back to reference Delimaris, I. (2013). Adverse effects associated with protein intake above the recommended dietary allowance for adults. ISRN Nutrition, 2013, 89–94.CrossRef Delimaris, I. (2013). Adverse effects associated with protein intake above the recommended dietary allowance for adults. ISRN Nutrition, 2013, 89–94.CrossRef
10.
go back to reference Geller, A. I., Shehab, N., Weidle, N. J., Lovegrove, M. C., Wolpert, B. J., Timbo, B. B., et al. (2015). Emergency department visits for adverse events related to dietary supplements. N Engl J Med, 373(16), 1531–1540.CrossRefPubMed Geller, A. I., Shehab, N., Weidle, N. J., Lovegrove, M. C., Wolpert, B. J., Timbo, B. B., et al. (2015). Emergency department visits for adverse events related to dietary supplements. N Engl J Med, 373(16), 1531–1540.CrossRefPubMed
11.
go back to reference Wilson, K. M., Klein, J. D., Sesselberg, T. S., et al. (2006). Use of complementary medicine and dietary supplements among US adolescents. J Adolesc Health, 38(4), 385–394.CrossRefPubMed Wilson, K. M., Klein, J. D., Sesselberg, T. S., et al. (2006). Use of complementary medicine and dietary supplements among US adolescents. J Adolesc Health, 38(4), 385–394.CrossRefPubMed
12.
go back to reference Eisenberg, M. E., Wall, M., & Neumark-Sztainer, D. (2012). Muscle-enhancing behaviors among adolescent girls and boys. Pediatrics, 130(6), 1019–1026.CrossRefPubMedPubMedCentral Eisenberg, M. E., Wall, M., & Neumark-Sztainer, D. (2012). Muscle-enhancing behaviors among adolescent girls and boys. Pediatrics, 130(6), 1019–1026.CrossRefPubMedPubMedCentral
13.
go back to reference Blanck, H. M., Serdula, M. K., Gillespie, C., Galuska, D. A., Sharpe, P. A., Conway, J. M., et al. (2007). Use of nonprescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc, 107, 441–447.CrossRefPubMed Blanck, H. M., Serdula, M. K., Gillespie, C., Galuska, D. A., Sharpe, P. A., Conway, J. M., et al. (2007). Use of nonprescription dietary supplements for weight loss is common among Americans. J Am Diet Assoc, 107, 441–447.CrossRefPubMed
15.
go back to reference Cohen, P. A., Maller, G., DeSouza, R., & Neal-Kababick, J. (2014). Presence of banned drugs in dietary supplements following FDA recalls. J Am Med Assoc, 312(16), 1691–1693.CrossRef Cohen, P. A., Maller, G., DeSouza, R., & Neal-Kababick, J. (2014). Presence of banned drugs in dietary supplements following FDA recalls. J Am Med Assoc, 312(16), 1691–1693.CrossRef
16.
go back to reference Cohen, P. A., Attipoe, S., Travis, J., Stevens, M., & Deuster, P. (2013). Caffeine content of dietary supplements consumed on military bases. JAMA Internal Medicine, 173(7), 592–594.PubMed Cohen, P. A., Attipoe, S., Travis, J., Stevens, M., & Deuster, P. (2013). Caffeine content of dietary supplements consumed on military bases. JAMA Internal Medicine, 173(7), 592–594.PubMed
18.
go back to reference Cohen, P. A., Travis, J. C., & Venhuis, B. J. (2014). A methamphetamine analog (N,alpha-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Testing and Analysis, 6(7–8), 805–807.CrossRefPubMed Cohen, P. A., Travis, J. C., & Venhuis, B. J. (2014). A methamphetamine analog (N,alpha-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Testing and Analysis, 6(7–8), 805–807.CrossRefPubMed
19.
go back to reference Dahlsrud, A. (2008). How corporate social responsiblity is defined: an analysis of 37 definitions. Corp Soc Responsib Environ Manag, 15(1), 1–13.CrossRef Dahlsrud, A. (2008). How corporate social responsiblity is defined: an analysis of 37 definitions. Corp Soc Responsib Environ Manag, 15(1), 1–13.CrossRef
20.
go back to reference Brennan, T. A., & Schroeder, S. A. (2014). Ending sales of tobacco products in pharmacies. J Am Med Assoc, 311(11), 1105–1106.CrossRef Brennan, T. A., & Schroeder, S. A. (2014). Ending sales of tobacco products in pharmacies. J Am Med Assoc, 311(11), 1105–1106.CrossRef
24.
go back to reference Waddington, F., Naunton, M., Kyle, G., Thomas, J., Cooper, G., & Waddinton, A. (2015). A systematic review of community pharmacist therapeutic knowledge of dietary supplements. International Journal of Clinical Pharmacology, 37(3), 439–446.CrossRef Waddington, F., Naunton, M., Kyle, G., Thomas, J., Cooper, G., & Waddinton, A. (2015). A systematic review of community pharmacist therapeutic knowledge of dietary supplements. International Journal of Clinical Pharmacology, 37(3), 439–446.CrossRef
27.
go back to reference Dorfman, L., Wallack, L., & Woodruff, K. (2005). More than a message: framing public health advocacy to change corporate practices. Health Education and Behavior, 32(3), 320–336.CrossRefPubMed Dorfman, L., Wallack, L., & Woodruff, K. (2005). More than a message: framing public health advocacy to change corporate practices. Health Education and Behavior, 32(3), 320–336.CrossRefPubMed
28.
go back to reference Heath, C., & Heath, C. (2007). Made to stick: why some ideas survive and others die. New York: Random House. Heath, C., & Heath, C. (2007). Made to stick: why some ideas survive and others die. New York: Random House.
29.
go back to reference Petty, R. E., & Cacioppo, J. T. (1979). Issue involvement can increase or decrease persuasion by enhancing message-relevant cognitive processes. J Pers Soc Psychol, 37, 1915–1926.CrossRef Petty, R. E., & Cacioppo, J. T. (1979). Issue involvement can increase or decrease persuasion by enhancing message-relevant cognitive processes. J Pers Soc Psychol, 37, 1915–1926.CrossRef
30.
go back to reference Ratner, R. K., & Riis, J. (2014). Communicating science-based recommendations with memorable and actionable guidelines. Proc Natl Acad Sci U S A, 111(Suppl 4), 13634–13641.CrossRefPubMedPubMedCentral Ratner, R. K., & Riis, J. (2014). Communicating science-based recommendations with memorable and actionable guidelines. Proc Natl Acad Sci U S A, 111(Suppl 4), 13634–13641.CrossRefPubMedPubMedCentral
Metadata
Title
Leveraging corporate social responsibility to improve consumer safety of dietary supplements sold for weight loss and muscle building
Authors
Anvita Kulkarni, BA
Ryan Huerto, MD, MPH
Christina A. Roberto, PhD
S. Bryn Austin, ScD
Publication date
01-03-2017
Publisher
Springer US
Published in
Translational Behavioral Medicine / Issue 1/2017
Print ISSN: 1869-6716
Electronic ISSN: 1613-9860
DOI
https://doi.org/10.1007/s13142-016-0434-4

Other articles of this Issue 1/2017

Translational Behavioral Medicine 1/2017 Go to the issue